Anavex Life Sciences (AVXL) Tops Q2 EPS by 2c

Anavex Life Sciences (NASDAQ: AVXL) reported Q2 EPS of ($0.06), $0.02 better than the analyst estimate of ($0.08).

For earnings history and earnings-related data on Anavex Life Sciences (AVXL) click here.

You May Also Be Interested In

• Opera Limited (OPRA) Misses Q2 EPS by 1c ; Offers Guidance
• BofA survey shows European fund managers eye growth despite caution
• Wedbush Starts Aktis Oncology (AKTS) at Outperform